title: Why are drug development programs growing in size and cost?  A view from industry.
authors.affiliation: Pfizer Inc, Groton, CT, USA.
authors.forename: J F
authors.initials: JF
authors.lastname: Niblack
mesh_terms: D017277:Drug Approval / Q000191:economics; D004345:Drug Industry / Q000639:trends; D005544:Forecasting; D006801:Humans; D013997:Time Factors; D014481:United States